Patients with metastatic renal cell carcinoma staged pT1-4 Nx M1 were enrolled ... ultrasonic examinations and bone scintigraphy before and 12 week after the first immunization.

IT IS well known that metastasis from a carcinoma of the kidney may occur many years after removal of the primary tumor. 1 2 3 The following example is reported because of the extraordinary ...

Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

Opdivo plus Cometyx resulted in a significant progression and survival benefits compared with Sutent in the first-line treatment of patients with advanced renal cell carcinoma.

GU ASCO annual meeting featured a kidney cancer session and a presentation by Dr. Michael Staehler discussing 18 F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients ... can cause decreased renal function, the US Food and Drug ...

The most common type of kidney cancer is called a Renal cell Carcinoma which accounts for ... that most kidney cancers are found before they spread (metastasize) to distant organs and cancers ...

Studied in combination with Opdivo, Cabometyx saw RCC patients surviving 11 months longer than Sunitinib patients.

Deferred cytoreductive nephrectomy (CN) may improve survival the most in patients with clear cell metastatic renal cell carcinoma (mRCC ... whereas bone metastases affected less than half.